GSK acquires oligonucleotide drug startup Elsie
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Establishing Asymchem’s first manufacturing footprint in Europe
This acquisition enables MTD to open new, strategic markets
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Arco Lab now holds a 50% stake in Neviton
Subscribe To Our Newsletter & Stay Updated